Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production
- PMID: 3934537
- DOI: 10.1056/NEJM198512123132403
Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production
Abstract
We studied 81 men (79 homosexuals and 2 drug abusers) with persistent lymphadenopathy to determine whether those at risk for AIDS-related opportunistic infections could be identified prospectively. (Sixty-nine of 76 [91 per cent] had antibodies to human T-cell lymphotropic virus Type III [HTLV-III], and 76 of 79 [96 per cent] had abnormal T4/T8 cell ratios.) During the follow-up period (mean +/- S.E.M., 12.9 +/- 0.5 months; range, 8 to 19), infections developed in none of 38 patients with lymphadenopathy alone and in only 1 of 15 (7 per cent) with antecedent herpes zoster infection; however, 13 of 28 (46 per cent) with lymphadenopathy accompanied by constitutional symptoms or oral candidiasis or both had opportunistic infections within the follow-up period. Among the results of various T-cell assays, only antigen-stimulated lymphocyte proliferation and gamma interferon generation, which were absent or barely measurable in those in whom AIDS ultimately developed, were of prognostic value. T cells from 15 patients, 11 of whom had constitutional symptoms or thrush, failed to generate antigen-induced gamma interferon; infections developed in 10 of these 15 (67 per cent) within a mean of 8.2 months. These results suggest that patients with AIDS-related complex who are at risk for opportunistic infections within a year can be identified by correlating clinical manifestations with antigen-stimulated T-cell responses--in particular, with the production of gamma interferon.
Similar articles
-
T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome.Arch Intern Med. 1988 Jul;148(7):1613-6. Arch Intern Med. 1988. PMID: 3132901
-
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.N Engl J Med. 1984 Aug 9;311(6):354-8. doi: 10.1056/NEJM198408093110602. N Engl J Med. 1984. PMID: 6738653
-
Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome.N Engl J Med. 1984 Apr 5;310(14):883-9. doi: 10.1056/NEJM198404053101404. N Engl J Med. 1984. PMID: 6422299
-
HIV infection and AIDS.P N G Med J. 1996 Sep;39(3):174-80. P N G Med J. 1996. PMID: 9795558 Review.
-
The clinical prognosis of HIV-1 infection: a review of 32 follow-up studies.J Gen Intern Med. 1988 Nov-Dec;3(6):525-32. doi: 10.1007/BF02596093. J Gen Intern Med. 1988. PMID: 3068338 Review.
Cited by
-
Antigen-stimulated human interferon-gamma generation: role of accessory cells and their expressed or secreted products.Clin Exp Immunol. 1989 Sep;77(3):397-402. Clin Exp Immunol. 1989. PMID: 2553309 Free PMC article.
-
Interleukin 2 production in HTLV-III/LAV infection: evidence of defective antigen-induced, but normal mitogen-induced IL-2 production.Clin Exp Immunol. 1986 Sep;65(3):489-96. Clin Exp Immunol. 1986. PMID: 2946497 Free PMC article.
-
Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.J Virol. 1995 Nov;69(11):6859-64. doi: 10.1128/JVI.69.11.6859-6864.1995. J Virol. 1995. PMID: 7474100 Free PMC article.
-
Patients with condyloma acuminatum exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer activity.J Clin Immunol. 1987 Jul;7(4):304-11. doi: 10.1007/BF00915552. J Clin Immunol. 1987. PMID: 3112173
-
Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.Clin Exp Immunol. 1988 May;72(2):179-85. Clin Exp Immunol. 1988. PMID: 2842093 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical